“…3,4 Cross-sectional structural MR imaging studies indicated reduced gray matter in elderly APOE*E4 carriers including healthy controls, subjective memory impairment, mild cognitive impairment (MCI), and AD. [5][6][7][8][9][10][11][12][13][14] In MCI and AD, the APOE*E4-related GM decrease seems to affect areas involved in AD pathology, notably the hippocampus, amygdala, and mesial temporal cortex [14][15][16][17] but also the left occipital, frontal, and anterior cingulate cortices. 14,18 In healthy elderly controls, the APOE*E4 effect on brain structure is less clear.…”